289 related articles for article (PubMed ID: 33506301)
21. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
22. Age at onset predicts outcome in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder from a United Kingdom population.
Papathanasiou A; Tanasescu R; Tench CR; Rocha MF; Bose S; Constantinescu CS; Jacob S
J Neurol Sci; 2021 Dec; 431():120039. PubMed ID: 34715481
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Neuromyelitis Optica Spectrum Disorders.
Chan KH; Lee CY
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445343
[TBL] [Abstract][Full Text] [Related]
26. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
27. A case of seropositive Neuromyelitis Optica in a paediatric patient with co-existing acute nephrotic syndrome.
Volkman T; Hemingway C
Mult Scler Relat Disord; 2017 Nov; 18():103-105. PubMed ID: 29141789
[TBL] [Abstract][Full Text] [Related]
28. Aquaporin-4 antibody positive short transverse myelitis associated with breast cancer.
Liao W; Li C; Tang Y; Huang F; Kuang H; Liang S; Yang Y
Mult Scler Relat Disord; 2019 May; 30():119-122. PubMed ID: 30771577
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A Rare Case of Advanced Breast Cancer with Intractable Nausea and Vomiting.
Miyagishima D; Anezaki T; Fukuda A; Watanabe H; Hata M; Eguchi M
Am J Case Rep; 2023 Nov; 24():e941808. PubMed ID: 37933098
[TBL] [Abstract][Full Text] [Related]
30. MRI Features of Aquaporin-4 Antibody-Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Chee CG; Park KS; Lee JW; Ahn HW; Lee E; Kang Y; Kang HS
AJNR Am J Neuroradiol; 2018 Apr; 39(4):782-787. PubMed ID: 29449281
[TBL] [Abstract][Full Text] [Related]
31. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
[TBL] [Abstract][Full Text] [Related]
32. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
33. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
35. Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
Sato DK; Callegaro D; Lana-Peixoto MA; Nakashima I; Fujihara K
Arq Neuropsiquiatr; 2014 Jun; 72(6):445-50. PubMed ID: 24964112
[TBL] [Abstract][Full Text] [Related]
36. Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Rosales D; Kister I
Curr Allergy Asthma Rep; 2016 Jun; 16(6):42. PubMed ID: 27167974
[TBL] [Abstract][Full Text] [Related]
37. [Clinical presentations of neuromyelitis optica spectrum disorders with ultra-longitudinally extensive transverse myelitis].
Huang X; Xu FF; Qian HR; Lei X; Qi XK; Xia DY
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(21):1658-1663. PubMed ID: 29925142
[No Abstract] [Full Text] [Related]
38. Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
de Sèze J; Kremer L; Collongues N
Rev Neurol (Paris); 2016; 172(4-5):256-62. PubMed ID: 27157418
[TBL] [Abstract][Full Text] [Related]
39. Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders.
Huh SY; Kim SH; Hyun JW; Jeong IH; Park MS; Lee SH; Kim HJ
Mult Scler; 2017 Mar; 23(3):413-419. PubMed ID: 28067584
[TBL] [Abstract][Full Text] [Related]
40. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
